Scientists at the UCLA Jonsson Comprehensive Cancer Center have identified potential new biomarkers that could indicate how someone diagnosed with metastatic melanoma will respond to immunotherapy treatment.
from News Medical Medical Research News Feed https://ift.tt/9MZtyrR
0 Comments